SNCA - Seneca Biopharma, Inc. Summary, Stock Quote and News | Benzinga

Market Overview

0.9165 -0 (-0.02%)

Data as of Dec 09, 2019

Prev. Close 0.9167
Price Open 0.9229
Volume 8,183
Day's Range 0.9018 - 0.9354
52 Wk Range 0.7 - 13.778
50 Day Moving Avg. 1
PE Ratio 0
Shares Outstanding 3.87M
Market Cap 3.54M

Trade SNCA stock with recommended broker Ally Invest. Commissions as low as $3.95.

Analyst Rating View All Ratings

19 Healthcare Stocks Moving In Friday's Pre-Market Session Lisa LevinFri, 22 Nov 2019 07:47:37 -0500
Seneca Biopharma Shares Tick To Session High On Large Uptick In Volume As Traders Circulate Word Of Int'l. Patent Grant For Alzhemier's Treatment Benzinga NewsdeskThu, 21 Nov 2019 15:04:28 -0500
The Daily Biotech Pulse: Patent Win For Cellectis, Hepion Proves Efficacy In Animal Model, Job Cuts At Neon Shanthi RexalineThu, 21 Nov 2019 07:22:05 -0500
Stocks That Hit 52-Week Lows On Wednesday Lisa LevinWed, 20 Nov 2019 10:37:04 -0500
The Daily Biotech Pulse: Endo's Cellulite Treatment Accepted For Review, Diffusion Pharma Reports Positive Glioblastoma Data Shanthi RexalineWed, 20 Nov 2019 07:25:05 -0500
Stocks That Hit 52-Week Lows On Tuesday Lisa LevinTue, 19 Nov 2019 11:28:53 -0500
The Daily Biotech Pulse: Therapix To Reverse Merge With CBD Company, Crispr Gene Editing Therapy Readout Shanthi RexalineTue, 19 Nov 2019 07:56:14 -0500
Stocks That Hit 52-Week Lows On Monday Lisa LevinMon, 18 Nov 2019 13:49:09 -0500
Stocks That Hit 52-Week Lows On Friday Lisa LevinFri, 15 Nov 2019 10:43:15 -0500
The Daily Biotech Pulse: Therapix Calls Off Merger, Alimera's Reverse Split, 2 Biotechs To Debut Shanthi RexalineFri, 08 Nov 2019 08:14:09 -0500
{{ story.title }} {{ story.author }}{{ story.created }}

Show more Loading articles...

Seneca Biopharma Reports Third Quarter 2019 Fiscal Results PRNewswireNov 14, 2019
Seneca Biopharma and Jiangsu QYuns Therapeutics Announce Development Plan for Potential Joint Pipeline at 7th China Renaissance Healthcare and Life Science Leadership Summit PRNewswireNov 01, 2019
Seneca Biopharma and Jiangsu QYuns Therapeutics Announce Development Plan for Potential Joint Pipeline at 7th China Renaissance Healthcare and Life Science Leadership Summit PRNewswireNov 01, 2019
Seneca Biopharma to Begin Trading Under New Ticker Symbol SNCA PRNewswireOct 31, 2019
{{ story.title }} {{ story.author }}{{ story.created }}

UCB's bimekizumab success in second late-stage psoriasis study Seeking AlphaNov 15, 2019
Seneca Biopharma reports Q3 results Seeking AlphaNov 14, 2019
Week In Review: BeiGene Forms Blockbuster $2.7 Billion Collaboration With Amgen Seeking AlphaNov 03, 2019
{{ story.title }} {{ story.author }}{{ story.created }}

Earnings View Earnings

Q3 2019	EST	Actual	Surprise
EPS:	Expected 2019-11-14
Rev:	Expected 2019-11-14

Q4 2019	EST	Actual	Surprise
EPS:	Expected 2020-03-20
Rev:	Expected 2020-03-20

Company Profile

Read More

Visit company website

Brokerage Center

Compare All Online Brokerages

Book A Demo

Learn How You Can Succeed In The Market With Benzinga Pro

Fastest Market News

Real-Time News Alerts

Customizable News Filters

Book A Demo